|
Protocol Number:
01-DK-0249
- Title:
Ingested Interferon-Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Diabetes Mellitus
- Number:
01-DK-0249
- Summary:
This study will see if interferon-alpha given early in the disease can stop or slow the immune attack on insulin-producing cells. In addition, the study will examine the safety and efficacy of interferon-alpha (given by mouth) to protect beta cell function. Patients between 3 and 25 years of age with Type 1 Diabetes Mellitus less then six weeks may be eligible for this study. All study-related tests and medications at the NIH Clinical Center are provided at no cost.
- Sponsoring Institute:
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Recruitment Detail
- Type:
Completed Study; data analyses ongoing
- Gender:
Male & Female
- Referral Letter Required:
No
- Population Exclusion(s):
None
- Eligibility Criteria:
This study is not currently recruiting new subjects. If you have questions about participating in a study, please contact the Patient Recruitment and Public Liaison Office, CC.
- Special Instructions:
Currently Not Provided
- Keyword(s):
-
Diabetes
-
Immunotherapy
-
Study Drug
- Recruitment Keyword(s):
-
Insulin Dependent Diabetes
-
Diabetes
-
Diabetes Mellitus
-
TIBM
- Condition(s):
-
Insulin-Dependent Diabetes Mellitus
- Investigational Drug(s):
-
Oral Interferon-Alpha
- Investigational Device(s):
- None
- Interventions:
-
Drug: Oral Interferon-Alpha
- Supporting Site:
-
National Institute of Diabetes and Digestive and Kidney Diseases
- Contact(s):
-
This study is not currently recruiting new subjects. If you have questions about participating in a study, please contact the Patient Recruitment and Public Liaison Office, CC.
- Citation(s):
-
The pathogenesis of insulin-dependent diabetes mellitus
-
Type I diabetes mellitus A chronic autoimmune disease
-
Ingested interferon alpha suppresses type I diabetes in non-obese diabetic mice
If you have:
Search The Studies | Help | Questions | Clinical Center Home | NIH Home
National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 01/30/2009
|
|